usell.com (PXHI) 10-K 31 Mar 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014	Mar. 25, 2015	Jun. 30, 2014
Document Information [Line Items]
Entity Registrant Name	usell.com, Inc.
Entity Central Index Key	1271075
Current Fiscal Year End Date	-19
Entity Filer Category	Smaller Reporting Company
Trading Symbol	USEL
Entity Common Stock, Shares Outstanding		7,533,817
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$16.30

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current Assets:
Cash and cash equivalents	$2,414,757	$489,166
Accounts receivable, net	141,327	184,718
Other receivables	0	29,257
Prepaid expenses and other current assets	99,529	95,808
Total Current Assets	2,655,613	798,949
Property and equipment, net	6,928	7,289
Intangible assets, net	852,093	806,964
Other assets	25,875	34,520
Total Assets	3,540,509	1,647,722
Current Liabilities:
Accounts payable	539,566	651,296
Accrued expenses	168,093	327,913
Deferred revenue	263,739	87,313
Derivative liability	0	1,001,385
Total Current Liabilities	971,398	2,067,907
Convertible notes payable, net of discount	0	246,128
Total Liabilities	971,398	2,314,035
Stockholders' Equity (Deficit):
Common stock; $0.0001 par value; 650,000,000 shares authorized; 7,572,703 and 4,973,073 shares issued, respectively, and 7,533,817 and 4,907,462 shares outstanding, respectively	753	490
Additional paid in capital	54,610,843	44,087,232
Accumulated deficit	-52,042,615	-44,754,133
Total Stockholders' Equity (Deficit)	2,569,111	-666,313
Total Liabilities and Stockholders' Equity (Deficit)	3,540,509	1,647,722
Series A Convertible Preferred Stock [Member]
Stockholders' Equity (Deficit):
Convertible preferred stock	10	0
Series B Convertible Preferred Stock [Member]
Stockholders' Equity (Deficit):
Convertible preferred stock	95	98
Series C Convertible Preferred Stock [Member]
Stockholders' Equity (Deficit):
Convertible preferred stock	15	0
Series E Convertible Preferred Stock [Member]
Stockholders' Equity (Deficit):
Convertible preferred stock	$10	$0

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets [Parenthetical] (USD $)	Dec. 31, 2014	Dec. 31, 2013
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	650,000,000	650,000,000
Common stock, shares issued	7,572,703	4,973,073
Common stock, shares outstanding	7,533,817	4,907,462
Series A Convertible Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	325,000	325,000
Preferred stock, shares issued	100,000	0
Preferred stock, shares outstanding	100,000	0
Preferred stock, liquidation value (in dollars)	$300,000	$0
Series B Convertible Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	4,000,000	4,000,000
Preferred stock, shares issued	951,250	976,250
Preferred stock, shares outstanding	951,250	976,250
Preferred stock, liquidation value (in dollars)	$951,250	$976,250
Series C Convertible Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	146,667	146,667
Preferred stock, shares issued	146,667	0
Preferred stock, shares outstanding	146,667	0
Series E Convertible Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	103,232	103,232
Preferred stock, shares issued	103,232	0
Preferred stock, shares outstanding	103,232	0

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenue	$6,665,429	$5,371,381
Costs and Expenses
Cost of revenue	1,921,175	416,233
Sales and marketing expenses	5,811,873	4,729,552
General and administrative expenses	4,659,710	4,480,070
Total operating expenses	12,392,758	9,625,855
Loss from Operations	-5,727,329	-4,254,474
Other (Expense) Income:
Interest income	2,527	1,808
Interest expense	-891,596	-334,678
Gain on settlements of accounts payable	9,038	188,709
Derivative expense - convertible notes payable	0	-61,495
Change in fair value of derivative liability - embedded conversion feature of Convertible Series A preferred stock	0	47,876
Change in fair value of derivative liability - convertible notes payable	-681,122	149,398
Total Other (Expense) Income, Net	-1,561,153	-8,382
Net Loss	($7,288,482)	($4,262,856)
Basic and Diluted Loss per Common Share:
Net loss per common share - basic and diluted (in dollars per share)	($1.15)	($0.95)
Weighted average number of common shares outstanding during the period - basic and diluted (in shares)	6,331,377	4,508,215

Consolidated_Statement_of_Chan

Consolidated Statement of Changes in Stockholders' Equity (Deficit) (USD $)	Total	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]	Series C Preferred Stock [Member]	Series D Preferred Stock [Member]	Series E Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit during Development Stage [Member]
Balance at Dec. 31, 2012	$1,169,659	$18	$208	$0	$35	$0	$314	$41,660,361	($40,491,277)
Balance (in shares) at Dec. 31, 2012		177,906	2,076,250	0	350,000	0	3,143,082
Conversion of Series A Preferred Stock to Common Stock	0	-18	0	0	0	0	6	12	0
Conversion of Series A Preferred Stock to Common Stock (in shares)		-177,906	0	0	0	0	59,302
Conversion of Series B Preferred Stock to Common Stock	0	0	-110	0	0	0	7	103	0
Conversion of Series B Preferred Stock to Common Stock (in shares)		0	-1,100,000	0	0	0	69,864
Conversion of Series D Preferred Stock to Common Stock	0	0	0	0	-35	0	117	-82	0
Conversion of Series D Preferred Stock to Common Stock (in shares)		0	0	0	-350,000	0	1,166,667
Reclassification of Derivative Liability upon Conversion of Series A PreferredStock to Common Stock	105,900	0	0	0	0	0	0	105,900	0
Reclassification of Derivative Liability uponConversion of Convertible Notes to Common Stock	93,568	0	0	0	0	0	0	93,568	0
Cashless exercise of warrants	0	0	0	0	0	0	3	-3	0
Cashless exercise of warrants (in shares)		0	0	0	0	0	31,579
Conversion of Convertible Notes and Accrued Interest to Common Stock	100,541	0	0	0	0	0	3	100,538	0
Conversion of Convertible Notes and Accrued Interest to Common Stock (in shares)		0	0	0	0	0	33,514
Stock based compensation	2,126,875	0	0	0	0	0	40	2,126,835	0
Stock based compensation (in shares)		0	0	0	0	0	403,454
Net loss	-4,262,856	0	0	0	0	0	0	0	-4,262,856
Balance at Dec. 31, 2013	-666,313	0	98	0	0	0	490	44,087,232	-44,754,133
Balance (in shares) at Dec. 31, 2013		0	976,250	0	0	0	4,907,462
Proceeds from the Sale of Series A Preferred Stock	300,000	10	0	0	0	0	0	299,990	0
Proceeds from the Sale of Series A Preferred Stock (in shares)		100,000	0	0	0	0	0
Issuance of Series C Preferred Stock in exchange for warrants	0	0	0	15	0	0	0	-15	0
Issuance of Series C Preferred Stock in exchange for warrants (in shares)		0	0	146,667	0	0
Conversion of Series B Preferred Stock to Common Stock	0	0	-3	0	0	0	0	3	0
Conversion of Series B Preferred Stock to Common Stock (in shares)		0	-25,000	0	0	0	1,587
Conversion of Convertible Notes and Accrued Interest to Common Stock	841,294	0	0	0	0	0	28	841,266	0
Conversion of Convertible Notes and Accrued Interest to Common Stock (in shares)		0	0	0	0	0	280,427
Conversion of Convertible Notes andAccrued Interest to Series E Preferred Stock	309,698	0	0	0	0	10	0	309,688	0
Conversion of Convertible Notes andAccrued Interest to Series E Preferred Stock (in shares)		0	0	0	0	103,232	0
Proceeds from the exercise of warrants	387,500	0	0	0		0	13	387,487	0
Proceeds from the exercise of warrants (in shares)		0	0	0		0	129,166
Reclassification of Derivative Liability upon Conversion of Convertible Notes to Common Stockand Series E Preferred Stock	1,682,507	0	0	0	0	0	0	1,682,507	0
Proceeds from the Sale of Common Stock, net of Offering Costs	5,383,313	0	0	0	0	0	214	5,383,099	0
Proceeds from the Sale of Common Stock, net of Offering Costs (in shares)		0	0	0	0	0	2,141,666
Contributed capital resulting from forgiveness of previously recorded accrued expenses	121,568	0	0	0	0	0	0	121,568	0
Stock based compensation	1,498,026	0	0	0	0	0	8	1,498,018	0
Stock based compensation (in shares)		0	0	0	0	0	73,509
Net loss	-7,288,482	0	0	0	0	0	0	0	-7,288,482
Balance at Dec. 31, 2014	$2,569,111	$10	$95	$15	$0	$10	$753	$54,610,843	($52,042,615)
Balance (in shares) at Dec. 31, 2014		100,000	951,250	146,667	0	103,232	7,533,817

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	($7,288,482)	($4,262,856)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation and amortization	615,907	362,993
Provision for (Recovery of) bad debt	20,148	-67,432
Stock based compensation expense	1,492,341	2,147,763
Amortization of debt issue costs into interest expense	8,645	2,325
Amortization of debt discount into interest expense	873,872	308,984
Lease termination expense	0	9,000
Gain on settlement of accounts payable	-9,038	-188,709
Derivative expense pertaining to convertible notes payable	0	61,495
Change in fair value of derivative liability - embedded conversion feature of convertible Series A preferred stock issuance	0	-47,876
Change in fair value of derivative liability - convertible notes payable	681,122	-149,398
Changes in operating assets and liabilities:
Accounts receivable	32,078	-33,838
Other receivables	20,422	42,045
Prepaid and other current assets	1,966	-27,991
Accounts payable	-102,692	205,922
Accrued expenses	-7,262	-225,295
Deferred revenues	176,426	85,004
Net Cash and Cash Equivalents Used In Operating Activities	-3,484,547	-1,777,864
CASH FLOWS FROM INVESTING ACTIVITIES:
Website development costs	-656,506	-540,942
Cash paid to purchase property and equipment	-4,169	-5,645
Net Cash and Cash Equivalents Used In Investing Activities	-660,675	-546,587
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock	6,424,999	0
Proceeds from sale of convertible Series A preferred stock	300,000	0
Proceeds from exercise of warrants	387,500	0
Proceeds from convertible notes payable	0	1,220,000
Cash paid for debt issue costs	0	-10,970
Cash paid for direct offering costs	-1,041,686	0
Net Cash and Cash Equivalents Provided By Financing Activities	6,070,813	1,209,030
Net Increase (Decrease) in Cash and Cash Equivalents	1,925,591	-1,115,421
Cash and Cash Equivalents - Beginning of Period	489,166	1,604,587
Cash and Cash Equivalents - End of Period	2,414,757	489,166
SUPPLEMENTARY CASH FLOW INFORMATION:
Cash Paid During the Period for Interest	0	0
Cash Paid During the Period for Taxes	0	0
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Derivative liability reclassified to Additional Paid in Capital upon conversion of Convertible Notes Payable	1,682,507	93,568
Conversion of Convertible Notes Payable and accrued interest to common stock	841,294	100,541
Common stock issued for services	51,695	35,100
Contributed capital resulting from forgiveness of previously recorded accrued expenses	121,568	0
Derivative liability reclassified to Additional Paid in Capital upon conversion of Series A preferred stock	0	105,900
Debt discount recorded on convertible notes payable	0	1,182,856
Cashless exercise of warrants	0	3
Series A preferred stock [Member]
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of preferred stock into common stock	0	18
Series B preferred stock [Member]
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of preferred stock into common stock	3	110
Series C preferred stock [Member]
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of Series C preferred stock in exchange for warrants	15	0
Series D preferred stock [Member]
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of preferred stock into common stock	0	35
Series E Preferred Stock [Member]
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of Convertible Notes Payable and accrued interest to Series E preferred stock	$309,698	$0

Organization_and_Business

Organization and Business	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1 – Organization and Business
	uSell.com, Inc., through its wholly-owned subsidiaries (collectively, “uSell” or “Company”), is a technology based company focused on creating an online marketplace where sellers can sell small consumer electronics to professional buyers using an ecommerce website-based platform. Through participation in the uSell marketplace, buyers can acquire high volumes of inventory in a cost effective manner, while minimizing the investment and risk associated with creating and running their own branded advertising campaigns.
	The Company utilizes consumer oriented advertising efforts, such as direct response television commercials, and various forms of Internet advertising to attract sellers to its website. The Company facilitates transactions by developing technology and logistics systems that seamlessly move product from sellers’ homes to buyers’ warehouses. The Company also provides its buyers with value added services, such as shipping kit fulfillments, check processing and analytics.
	Reverse Stock Split
	On January 21, 2014, the Company effected a 1-for-15 reverse stock split of its common stock (“Reverse Split”). As a result of the Reverse Split, every fifteen shares of common stock was combined into one share of common stock. Immediately after the January 21, 2014 effective date, the Company had 4,907,462 shares of common stock outstanding. All share and per share amounts have been retroactively restated to reflect the Reverse Split. The authorized number of shares of common stock and the par value remained the same. The Reverse Split did not affect the shares of preferred stock outstanding, however it did affect the number of common stock shares issuable to holders upon conversion.

Going_Concern

Going Concern	12 Months Ended
	Dec. 31, 2014
Going Concern [Abstract]
Going Concern Disclosure [Text Block]	Note 2 – Going Concern
	As reflected in the accompanying consolidated financial statements, the Company had a net loss of approximately $7,288,000 and net cash and cash equivalents used in operations of approximately $3,485,000 for the year ended December 31, 2014. The Company has an accumulated deficit of approximately $52,043,000 at December 31, 2014. The Company does not yet have a history of financial stability. Historically, the principal source of liquidity has been the issuance of debt and equity securities. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
	The ability of the Company to continue as a going concern is dependent on management's plans, which include the implementation in March 2015 of cost cutting measures, including a reduction in headcount and a decrease in our marketing and advertising spend. Additionally the Company is exploring a number of options to provide working capital including strategic partnerships and seeking equity or debt financings. Management cannot be sure that the Company will consummate a transaction or financing that will enable the Company to meet its working capital needs. Future efforts to raise additional funds may not be successful or they may not be available on acceptable terms, if at all.
	The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Significant_Accounting_Policie

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 3 – Significant Accounting Policies
	Basis of Presentation and Principals of Consolidation
	The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
	Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from these estimates.
	Cash and Cash Equivalents
	All highly liquid investments with an original maturity of 90 days or less when purchased are considered to be cash equivalents. Cash equivalents are stated at cost, which approximates market value. Cash equivalents generally consist of money market accounts.
	The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institutions. At times, the Company’s cash may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limit.
	Accounts Receivable and Other Receivables
	Accounts receivable and other receivables represent obligations from the Company’s customers. The Company periodically evaluates the collectability of its accounts receivable and other receivables and considers the need to record an allowance for doubtful accounts based upon historical collection experience and specific information. Actual amounts could vary from the recorded estimates. The allowance for doubtful accounts was $9,642 and $3,500 at December 31, 2014 and 2013, respectively.
	Property and Equipment
	Property and equipment represent costs associated with leasehold improvements, software, and computer and office equipment. Property and equipment is stated at cost. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets.
	Intangible Assets
	The Company’s intangible assets pertain to capitalized software costs and its website domain address. The Company capitalizes costs related to software developed or obtained for internal use when management commits to funding the project, the project completes the preliminary project stage and the software will be used to perform the function intended. Capitalization of such costs ceases when the project is substantially complete and ready for its intended use.
	The Company periodically reviews the carrying values of its long-lived assets when events or changes in circumstances indicate that it is more likely than not that their carrying values may exceed their fair values, and records an impairment charge when considered necessary. When circumstances indicate that an impairment of value may have occurred, the Company tests such assets for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of such assets and their eventual disposition to their carrying amounts. If the undiscounted future cash flows are less that the carrying amount of the asset, an impairment loss, measured as the excess of the carrying amount of the asset over its estimated fair value, is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.
	Convertible Instruments
	The Company reviews all of its convertible instruments for the existence of an embedded conversion feature which may require bifurcation, if certain criteria are met. These criteria include circumstances in which:
		a)	The economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract,
		b)	The hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable GAAP with changes in fair value reported in earnings as they occur, and
		c)	A separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to certain requirements (except for when the host instrument is deemed to be conventional).
	A bifurcated derivative financial instrument may be required to be recorded at fair value and adjusted to market at each reporting period end date. In addition, the Company may be required to classify certain stock equivalents issued in connection with the underlying debt instrument as derivative liabilities.
	For convertible instruments that the Company has determined should not be bifurcated from their host instruments, the Company records discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. Also when necessary, the Company records deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the financing transaction and the effective conversion price embedded in the preferred shares.
	Finally, if necessary, the Company will determine the existence of liquidated damage provisions. Liquidated damage provisions are not marked to market, but evaluated based upon the probability that a related liability should be recorded.
	Common Stock Purchase Warrants and Derivative Financial Instruments
	The Company reviews any common stock purchase warrants and other freestanding derivative financial instruments at each balance sheet date and classifies them on the consolidated balance sheet as:
		a)	Equity if they (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement), or
		b)	Assets or liabilities if they (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).
	The Company assesses classification of its common stock purchase warrants and other freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
	Revenue Recognition
	Revenue is recognized when all of the following conditions exist: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred, (3) the sales price is fixed or determinable, and (4) collectability is reasonably assured.
	Seller Electronics Referrals
	Sellers responding to the Company’s advertising campaigns go to uSell’s website where they can search for the items they wish to sell using a streamlined point and click interface. Once they have identified their device, they are asked a single question to describe the condition of the device. At this point, they are presented with the “best match,” or uSell’s recommended offer from one of its buyers. The Company offers this recommendation based on both the price offered by the buyer relative to other buyers and the quality of ratings of the buyer relative to other buyers. The seller may choose to view a larger list of offers from all buyers interested in purchasing their device. During 2013, and into 2014, the Company earned up front “lead fees” from buyers when sellers accepted offers on its website and filled out a form to request a free shipping kit. This fee was received regardless of whether the sellers ultimately sent in their devices to the buyers. The Company recognized revenue upon online acceptance of the buyer’s offer by the seller. The Company records payments received from buyers in advance of offer acceptance as deferred revenue at the time payment is received.
	During 2013, the Company’s buyers paid fees based on the demand for the individual item which the seller was seeking to sell. Fees were not based on the value of the item sold. For instance, an iPhone might have had a higher fee than an Android, even if that particular Android had a higher offer price to the seller.
	Beginning in February 2014, the Company started a transition of its business model, which was phased in over the subsequent six weeks. Under the new model, buyers pay uSell a commission only when they pay the seller for a received device and the Company recognizes revenue upon payment to the seller.
	As a further development to the Company’s business model, in October 2014, the Company launched its “Managed by uSell” service, whereby the Company partnered with a third party logistics company to inspect, wipe and process devices before passing them along to buyers. Under this new model, title to a device passes to uSell upon issuance of payment to the seller, which is generally within one to two days from the receipt of the device at the third party warehouse. Title to a device is then transferred to the buyer upon shipment to the buyer. As a result, starting in October 2014, the Company began recognizing the full value of the processed devices in both revenues and cost of revenues.
	Fulfillment Revenue
	The Company offers fulfillment services on behalf of its buyers for the items sold by sellers. The Company acts as the agent in these transactions, passing orders booked by its buyers to its vendors, who then assemble the kits and mail them directly to the sellers. The Company earns a standard fee from its buyers and recognizes revenue upon shipment of the kits to the sellers. The Company evaluated the presentation of revenue on a gross versus net basis and determined that since the Company performs as an agent without assuming the risks and rewards of ownership of the goods, revenue should be reported on a net basis.
	Advertising Revenue
	Advertising revenues primarily come from payments for text-based sponsored links and display advertisements. Generally, the Company’s advertisers pay the Company on a cost per click, or CPC basis, which means advertisers pay only when someone clicks on one of their advertisements, or on a cost per thousand impression basis, or CPM. Paying on a CPM basis means that advertisers pay the Company based on the number of times their advertisements appear on the Company’s websites or mobile applications. Advertising revenue is recognized as income when the advertising services are rendered.
	Cost of Revenue
	Cost of revenue consists primarily of costs to maintain its website, including amortization expense on its technology platform software. Beginning in October 2014, cost of revenue pertaining to the sale of devices to buyers includes the cost of acquiring the device, as well as any other direct costs and expenses required to inspect and process the devices internally before shipping them to the buyers.
	Advertising
	Advertising costs are expensed as they are incurred and are included in sales and marketing expenses. Advertising expense amounted to approximately $5,498,000 and $4,461,000 for the years ended December 31, 2014 and 2013, respectively.
	Share-Based Payment Arrangements
	The Company accounts for stock options in accordance with Accounting Standards Codification (“ASC”) 718, “Compensation - Stock Compensation.” ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards, and at subsequent exercise or settlement for cash-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and is estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights.
	Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company’s initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense in the accompanying consolidated statements of operations.
	Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost.
	Income Taxes
	The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
	ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2014. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
	The Company may be subject to potential income tax examinations by federal or state authorities. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. Management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
	The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest as of December 31, 2014.
	Net Loss per Share
	Basic loss per share (“EPS”) is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method, and convertible debt or convertible preferred stock, using the if-converted method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive.
	The computation of basic and diluted loss per share for the years ended December 31, 2014 and 2013 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:
			Years Ended December 31,
			2014		2013
	Convertible Notes Payable				373,333
	Convertible Series A Preferred Stock		100,000		-
	Convertible Series B Preferred Stock		60,415		62,002
	Convertible Series C Preferred Stock		146,667		-
	Convertible Series E Preferred Stock		103,232		-
	Unvested Restricted Stock		48,886		65,610
Unvested Restricted Stock Units		509,666		183,331
Stock Warrants		802,520		476,270
Stock Options		604,625		557,413
		2,376,011		1,717,959
Legal Proceedings
From time to time, The Company is a party to or otherwise involved in legal proceedings arising in the normal and ordinary course of business. As of the date of this report, the Company is not aware of any proceeding, threatened or pending, against the Company which, if determined adversely, would have a material effect on its business, results of operations, cash flows or financial position.
Customer Concentrations
The following table shows significant concentrations in the Company’s revenues and accounts receivable for the periods indicated.
		Percentage of
		Revenue During the
		Year Ended
		December 31,
		2014			2013
Buyer A			15	%		8	%
Buyer B			7	%		18	%
Buyer C			6	%		25	%
		Percentage of Accounts
		Receivable at
		December 31,
		2014			2013
Buyer AA			24	%		35	%
Buyer BB			3	%		14	%
Buyer CC			-	%		17	%
Recent Accounting Pronouncements
In July 2013, the Financial Accounting Standards Board (“FASB”) issued ASU, No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” (“ASU 2013-11”). ASU 2013-11 provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013, with an option for early adoption. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.
In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” (ASU 201-09). ASU 201-09 provides guidance for revenue recognition and affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets and supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition,” and most industry-specific guidance. The core principle of ASU 2014-09 is the recognition of revenue when a company transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, companies will need to use more judgment and make more estimates than under the current guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for fiscal years beginning after December 15, 2016 and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). Early adoption is not permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-09 will have on the Company’s consolidated financial statements and disclosures.
In June 2014, the FASB issued ASU No. 2014-12, “Compensation - Stock Compensation” (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could be Achieved after the Requisite Service Period (“ASU 2014-12”). ASU 2014-12 affects entities that grant their employees share-based payments in which terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments in ASU 2014-12 require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for fiscal years beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-12 will have on the Company’s consolidated financial statements and disclosures.
In August 2014, the FASB issued ASU 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15 provides guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company’s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in ASU 2014-15 are effective for annual reporting periods ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. The Company will adopt the methodologies prescribed by ASU 2014-15 by the date required, and does not anticipate that the adoption of ASU 2014-15 will have a material effect on its financial position or results of operations.
Subsequent events
The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements were issued for potential recognition or disclosure. Any material events that occur between the balance sheet date and the date that the consolidated financial statements were issued are disclosed as subsequent events, while the consolidated financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements.

Fair_Value

Fair Value	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	Note 4 – Fair Value
	The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of the Company’s assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
		Level 1:	Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
		Level 2:	Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
		Level 3:	Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.
	The following are the major categories of liabilities measured at fair value on a recurring basis at December 31, 2014 and 2013, using quoted prices in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):
			At December 31,
			2014				2013
			Assets		Liabilities		Assets		Liabilities
	Level 1
	None		$	-	$	-	$	-	$	-
	Level 2
	None			-		-		-		-
	Level 3
	Derivative liability			-		-		-		1,001,385
			$	-	$	-	$	-	$	1,001,385
	The following table reflects the change in fair value of the Company’s derivative liabilities for the years ended December 31, 2014 and 2013:
			Year Ended December 31,
			2014				2013
			Assets		Liabilities		Assets		Liabilities
	Balance at beginning of period		$	-	$	1,001,385	$	-	$	153,776
	Change in value of derivative liability - Series A preferred stock			-		-		-		-47,876
	Reclassification of price protection feature to additional paid in capital - Series A preferred stock			-		-		-		-105,900
	Derivative liability arising from issuance of convertible notes payable			-		-		-		1,244,351
	Change in value of derivative liability - convertible notes			-		681,122		-		-149,398
	Reclassification of price protection feature to additional paid in capital - converted notes			-		-1,682,507		-		-93,568
	Balance at end of period		$	-	$	-	$	-	$	1,001,385
	The Company has determined the estimated fair value amounts using available market information and appropriate methodologies. However, considerable judgment is required in interpreting market data to develop the estimates of fair value. The estimates presented are not necessarily indicative of the amounts that the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts. The Company has based these fair value estimates on pertinent information available as of the respective balance sheet dates and has determined that, as of such dates, the carrying value of all financial instruments approximates fair value.

Property_and_Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 5 – Property and Equipment
	Property and equipment consists of the following at December 31, 2014 and 2013:
						Estimated
		2014		2013		Useful Life
	Hardware and Software	$	14,216	$	14,721	3 years
	Furniture and Fixtures		5,645		5,645	3 years
			19,861		20,366
	Less: Accumulated Depreciation		-12,933		-13,077
	Property and Equipment, Net	$	6,928	$	7,289
	Depreciation expense on property and equipment amounted to $4,530 and $4,862 for the years ended December 31, 2014 and 2013, respectively.

Intangible_Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets Disclosure [Text Block]	Note 6 – Intangible Assets
	Intangible assets consist of the following:
		Capitalized		Website
		Software		Domain		Total
	Gross value at December 31, 2014	$	1,974,482	$	67,752	$	2,042,234
	Accumulated amortization at December 31, 2014		-1,122,389		-67,752		-1,190,141
	Net value at December 31, 2014	$	852,093	$	-	$	852,093
	Gross value at December 31, 2013	$	1,317,976	$	67,752	$	1,385,728
	Accumulated amortization at December 31, 2013		-511,012		-67,752		-578,764
	Net value at December 31, 2013	$	806,964	$	-	$	806,964
	Intangible assets are amortized on a straight-line basis over their estimated useful lives of two to three years. Amortization expense amounted to $611,377 and $358,131 for the years ended December 31, 2014 and 2013, respectively.
	Future annual estimated amortization expense is summarized as follows:
	Years ending December 31,
	2015	$	470,110
	2016		261,281
	2017		120,702
		$	852,093

Convertible_Notes

Convertible Notes	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Note 7 – Convertible Notes
	During the year ended December 31, 2013, the Company borrowed $1,220,000 and issued convertible notes payable (the “Convertible Notes”) which the Company used for working capital purposes. The Convertible Notes were convertible at $3.00 per share, after giving effect to the Reverse Split, due two years from the date of the investment and bore interest of 5% per annum payable in common stock upon maturity or conversion. The Convertible Notes automatically converted if the Company consummated (i) a financing of at least $1 million in which it issued common stock or common stock equivalents for a price greater than $3.75 per share or (ii) a change of control transaction whereby a majority of the Company’s outstanding voting stock was sold or there was a sale of substantially all of the Company’s assets, or (iii) the closing price of the Company’s common stock was more than $4.50 for 10 consecutive trading days. Additionally, investors had price protection on future non-exempted issuances at a price lower than $3.00 per share of common stock or common stock equivalent.
	At the time of the issuances, the Company determined that the price protection feature on the Convertible Notes constituted a derivative liability and estimated the fair value of such liability to be $1,244,351 using the Black-Scholes option pricing model. The Company recorded the fair value of the liability of $1,244,351 as a derivative liability since the price protection feature of the Convertible Notes represented a variable conversion feature. Of this amount, the Company recorded $1,182,856 as a discount to the Convertible Notes and $61,495 as derivative expense.
	During the year ended December 31, 2013, the Company issued 33,514 shares of its common stock in connection with the conversion of $100,000 of Convertible Notes, along with accrued interest of $541.
	In February 2014, holders of $820,000 Convertible Notes converted their principal, plus accrued interest of $21,294, into 280,427 shares of common stock. In addition, in February 2014, a holder of a $300,000 Convertible Note converted his note, plus accrued interest of $9,698, into 103,232 shares of newly designated Series E Preferred Stock (see Note 9). On the date of conversion, the Company determined the fair value of the derivative liability to be $1,682,507 using the Black-Scholes option pricing model with the following assumptions:
	Risk-free interest rate	0.22	%
	Expected dividend yield	0	%
	Expected volatility	239.41	%
	%Expected term	1.35 - 1.77 years
	The Company recorded an expense of $681,122 during the year ended December 31, 2014, representing the net change in the fair value of the derivative liability pertaining to the Convertible Notes through the date of conversion and, as the derivative liability was eliminated upon conversion, recorded $1,682,507 as additional paid in capital.
	The Company evaluated the conversion of the $300,000 Convertible Note into the Series E Preferred Stock using the applicable guidance in ASC 470-20, “Debt with Conversion and Other Options,” whereby if a convertible instrument is converted to equity securities of the debtor pursuant to an inducement offer, the debtor shall recognize an expense equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms. No gain or loss was recognized by the Company upon the conversion of the Convertible Notes into the Series E Preferred Stock since the fair value of the securities transferred was determined to be equal to the fair value of the securities issuable pursuant to the original conversion terms.
	The discount of $1,182,856 was being accreted to non-cash interest expense over the contractual term of the Convertible Notes. During the years ended December 31, 2014 and 2013, accretion of the discount amounted to $873,872 and $308,984, respectively. Contractual interest expense on the Convertible Notes amounted to $8,745 and $22,788 for the years ended December 31, 2014 and 2013, respectively.
	The Company incurred fees associated with the closing of the Convertible Notes of $10,970. These amounts were recorded as other assets and were being amortized to interest expense over the contractual term of the Convertible Notes. During the years ended December 31, 2014 and 2013, accretion of the fees amounted to $8,645 and $2,325, respectively.
	At December 31, 2014, all Convertible Notes have been converted and, as such, no balances remain outstanding.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 8 – Commitments and Contingencies
	The Company leases space for operations, sales, customer support and corporate purposes under a lease agreement that expires in August 2015. The lease contains provisions requiring the Company to pay maintenance, property taxes and insurance. For the years ended December 31, 2014 and 2013, the aggregate rent expense was approximately $81,000 and $95,000, respectively. Future minimum commitments are $51,750 for the year ended December 31, 2015.

Preferred_Stock

Preferred Stock	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Preferred Stock [Text Block]	Note 9 – Preferred Stock
	Convertible Series A Preferred Stock
	As of December 31, 2014, the Company has 100,000 shares of Convertible Series A Preferred Stock, with a par value of $0.0001 per share (“Series A”), outstanding. The Series A has:
		a)	Seniority and a liquidation preference over all classes of common stock, but is subordinate to the Company’s Convertible Series B Preferred Stock;
		b)	Voting rights and powers equal to the voting rights and powers of the Company’s common stock. Each share of  Series A is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		c)	A stated liquidation value of $3.00 per share;
		d)	No stated dividends; and
		e)	An option by the holder to convert each share into common shares at a rate of one share of common for each share of Series A.
	On January 27, 2014, the Company sold 100,000 shares of Series A for proceeds of $300,000.
	Convertible Series B Preferred Stock
	As of December 31, 2014, the Company has 951,250 shares of Convertible Series B Preferred Stock, with a par value of $0.0001 per share, (“Series B”) outstanding. The Series B has:
		(a)	Seniority to all classes of common and preferred stock existing or issued in the future;
		(b)	Voting rights and powers equal to the voting rights and powers of the Company’s common stock. Each share of Series B is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		(c)	A stated liquidation value of $1.00 per share, and a liquidation preference of the greater of $1.00 per share, or the amount that would be due if all Series B shares had been converted to common stock immediately prior to the liquidation event;
		(d)	No stated dividends;
		(e)	An option by the holder to convert each share into common shares at a rate of 0.0635 shares of common for each share of Series B.
	On February 4, 2014, a holder of 25,000 shares of the Company’s 2010 Series B PS converted his shares into 1,587 shares of common stock.
	Convertible Series C Preferred Stock
	On January 24, 2014, the Company’s Board of Directors authorized the issuance of up to 146,667 shares of Convertible Series C Preferred Stock (“Series C”), with a par value of $0.0001 per share. The Series C has:
		a)	Voting rights and powers equal to the voting rights and powers of the Company’s common stock. Each share of Series C is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		b)	No stated dividends; and
		c)	An option by the holder to convert each share into common shares at a rate of one share of common for each share of Series C.
	On January 27, 2014, the Company issued 146,667 shares of Series C in exchange for 216,667 warrants, which were cancelled.
	As of December 31, 2014, there are 146,667 shares of Series C outstanding.
	Series E Preferred Stock
	On March 3, 2014, the Company’s Board of Directors authorized the issuance of up to 103,232 shares of Convertible Series E Preferred Stock (“Series E”), with a par value of $0.0001 per share. The Series E has:
		a)	Voting rights and powers equal to the voting rights and powers of the Company’s common stock. Each share of Series E is entitled to the number of votes that the holder would be entitled to upon the conversion of the shares into common stock;
		b)	No stated dividends; and
		c)	An option by the holder to convert each share into common shares at a rate of one share of common for each share of Series E.
	In February 2014, the Company issued 103,232 shares of Series E upon the conversion of a $300,000 Convertible Note, plus accrued interest of $9,698.
	As of December 31, 2014, there are 103,232 shares of Series E outstanding.

Public_Offering

Public Offering	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Stockholders Equity Note Public Offering Disclosure [Text Block]	Note 10 - Public Offering
	On August 15, 2014, the Company sold an aggregate of 1,550,000 units at $3.00 per unit (“Units”) for gross proceeds of $4,650,000. Each Unit consisted of one share of the Company’s common stock and one-half warrant. Each warrant is exercisable for five years and entitles the holder to purchase one share of common stock at an exercise price of $3.20 per share. The Company estimated the fair value of the warrant to be $1,204,759, using the Black-Scholes option pricing model. The fair value of the warrant was estimated as of the date of issuance using the following assumptions: (1) expected volatility of 60.7%, (2) risk-free interest rate of 1.55% and (3) expected life of five years. The Company accounted for the fair value of the warrant as a cost of the offering resulting in a charge directly to stockholders’ equity. Dawson James Securities, Inc. (“Dawson James”), the Company’s placement agent for the offering, received a commission of $559,900. In addition, the Company sold Dawson James, for $100, an option to purchase up to a total of 93,000 Units, exercisable for five years at $3.75 per Unit (or an aggregate exercise price of $348,750). The Company estimated the fair value of the unit purchase option to be $133,355, using the Black-Scholes option pricing model. The fair value of the unit purchase option was estimated as of the date of grant using the following assumptions: (1) expected volatility of 60.7%, (2) risk-free interest rate of 1.55% and (3) expected life of five years. The Company accounted for the fair value of the unit purchase option, inclusive of the receipt of $100 cash payment, as a cost of the offering resulting in a charge directly to stockholders’ equity. Net proceeds, after the payment of commissions and legal and other expenses of $946,136, amounted to $3,703,864.

Common_Stock

Common Stock	12 Months Ended
	Dec. 31, 2014
Equity [Abstract]
Stockholders Equity Note Disclosure [Text Block]	Note 11 - Common Stock
	In February and March 2014, the Company sold an aggregate of 591,666 shares of its common stock, par value $0.0001, in a private placement offering for gross proceeds of $1,774,999. Palladium Capital Advisors, LLC (“Palladium”) acted as the Company’s placement agent for the offering, received a commission of $75,000 and was issued 22,083 five-year warrants exercisable at $3.00 per share. The Company estimated that the fair value of warrant was $62,241 using the Black-Scholes option pricing model. The fair value of the warrant granted to Palladium was estimated as of the date of grant using the following assumptions: (1) expected volatility of 58.9%, (2) risk-free interest rate of 1.53% and (3) expected life of five years. The Company accounted for the fair value of the warrant as a cost of the private placement offering resulting in a charge directly to stockholders’ equity. Net proceeds, after the payment of commissions and legal and other expenses of $95,550, amounted to $1,679,449.
	Shares Granted to Directors, Consultants and Employees
	In February 2013, the Company granted 233,333 fully vested shares of common stock, having a fair value of $437,500 based on the quoted closing trading price of the Company’s common stock as of the grant date, to its former Chief Executive Officer. The Company recorded $437,500 as compensation expense pertaining to this grant during the year ended December 31, 2013.
	In June 2013, the Company granted 1,333 fully-vested shares of common stock, having a fair value of $4,000 based on the quoted closing trading price of the Company’s common stock as of the grant date, to a third party consultant for services provided. The Company recorded $4,000 as professional fees expense pertaining to this grant during the year ended December 31, 2013.
	On January 27, 2014, the Company entered into a six month joint marketing agreement with a third party consultant. Pursuant to the terms of the agreement, the Company was required to pay a cash fee of $40,000 for the first month of service, $30,000 for the second and third month and $10,000 per month thereafter. Additionally, the Company issued the consultant 30,000 fully vested shares of common stock, having a fair value of $123,744, based on the quoted closing trading price of the Company’s common stock as of the grant date. The Company recorded $123,744 as compensation expense pertaining to this grant during the year ended December 31, 2014.
	On January 30, 2014, the Company granted 2,000 fully-vested shares of common stock, having a fair value of $6,056, based on the based on the value of services provided, to an advisor for services provided. The Company recorded $6,056 as professional fees expense pertaining to this grant during the year ended December 31, 2014.
	On April 10, 2014, the Company entered into agreements with Michael Brauser, former Chairman of the Board of Directors of the Company, and Doug Feirstein, a former director of the Company, through which each agreed within 90 days to prematurely exercise 216,666 warrants and 33,333 warrants, respectively, exercisable at $3.00 per share (after giving effect to the reverse stock split), with one-half exercised for cash and the other half exchanged for restricted stock units (“RSUs”). Mr. Brauser exercised and exchanged his warrants in July 2014 by paying $324,999 of cash and receiving 108,333 shares of common stock and 108,333 fully vested RSUs to be delivered on July 18, 2019. Mr. Feirstein exercised and exchanged his warrants in July 2014 by paying $50,000 of cash and receiving 16,667 shares of common stock and 16,666 fully vested RSUs to be delivered on July 18, 2019.

StockBased_Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 12 - Stock-Based Compensation
	Stock Option Grants
	On November 21, 2014 and October 30, 2013, the Company amended its 2008 Equity Incentive Plan (the “Plan”) to increase the number of authorized shares of common stock under the Plan by 300,000 and 250,000 shares, respectively. The Company is now authorized to issue 584,296 shares under the Plan. The Plan is administered by the board of directors. Under the Plan, the board of directors is authorized to grant awards to employees, consultants and any other persons to whom the Plan is applicable and to determine the number and types of such awards and the terms, conditions, vesting and other limitations applicable to each such award. The Plan provides for the issuance of both incentive stock options (“ISO’s”) and non-qualified stock options (“NQO’s”). ISO’s can only be granted to employees and NQO’s can be granted to directors, officers, employees, consultants, independent contractors and advisors. As of December 31, 2014, there were 263,918 shares of common stock available for issuance under the Plan.
	The fair value of options is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, the expected life is based on the estimated average of the life of options using the simplified method, and forfeitures are estimated on the date of grant based on certain historical data. The Company utilizes the simplified method to determine the expected life of its options due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.
	Forfeitures are required to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
	During 2013, the Company granted 144,333 stock options to employees for future services. These options had a fair value of $384,387 using the Black-Scholes option-pricing model with the following assumptions:
	Risk free interest rate		0.54% - 1.37	%
	Expected dividends		0	%
	Expected volatility		204.36% - 219.25	%
	Expected term		5 years
	The options are exercisable at exercise prices ranging from $3.00 to $4.50 per share over a five-year term and vest over four years. The Company recorded $80,411 and $35,490 during the years ended December 31, 2014 and 2013, respectively, as compensation expense pertaining to this grant.
	During the year ended December 31, 2014, the Company granted 128,332 stock options to employees for future services. These options had a fair value of $184,423, using the Black-Scholes option pricing model with the following assumptions:
	Risk free interest rate		1.19% - 1.43	%
	Expected dividends		0	%
	Expected volatility		56.89% - 60.87	%
	Expected term		3.75 – 4.00 years
	The options are exercisable at exercise prices ranging from $2.69 to $5.15 per share over a five-year term and vest over four years. The Company recorded $27,152 during the year ended December 31, 2014 as compensation expense pertaining to these grants.
	Including prior period grants and the above grants, the Company recorded non-cash compensation expense of $521,953 and $1,342,525 during the years ended December 31, 2014 and 2013, respectively, pertaining to stock option grants.
	The weighted-average grant date fair value of options granted during the years ended December 31, 2014 and 2013 was $1.44 and $2.66, respectively. Total unrecognized compensation expense related to unvested stock options at December 31, 2014 amounts to $642,062 and is expected to be recognized over a weighted average period of 2.7 years.
	The following table summarizes the Company’s stock option activity for the year ended December 31, 2014:
							Weighted
							Average
					Weighted		Remaining
					Average		Contractual
			Number of		Exercise		Life		Aggregate
			Options		Price		(in Years)		Intrinsic Value
	Outstanding - December 31, 2013			557,413	$	4.98		4	$	5,250
	Granted			128,332		3.41
	Exercised			-		-
	Forfeited or Canceled			-81,120		4.36
	Outstanding - December 31, 2014			604,625	$	4.73		3.3	$	-
	Exercisable - December 31, 2014			348,770	$	5.9		3.2	$	-
	The following table summarizes the Company’s stock option activity for non-vested options for the year ended December 31, 2014:
					Weighted
					Average
			Number of		Grant Date
			Options		Fair Value
	Balance at December 31, 2013			237,040	$	4.45
	Granted			128,332		1.44
	Vested			-98,558		-5.45
	Forfeited or Canceled			-10,959		-4.36
	Balance at December 31, 2014			255,855	$	2.65
	Warrants
	The following summarizes the Company’s warrant activity for the year ended December 31, 2014:
							Weighted
					Weighted		Average
					Average		Remaining		Aggregate
			Number of		Exercise		Contractual Life		Intrinsic
			Warrants		Price		(in Years)		Value
	Outstanding - December 31, 2013			476,269		3.02		3.1	$	-
	Granted			797,083		3.19
	Exercised			-254,165		-3
	Forfeited or Canceled			-216,667		-3
	Outstanding – December 31, 2014			802,520	$	3.21		4.6	$	-
	Exercisable – December 31 2014			802,520	$	3.21		4.6	$	-
	During the year ended December 31, 2014, a holder exercised 4,166 warrants for proceeds of $12,500.
	As discussed in Note 11, in February 2014, in connection with the private placement offering of the Company’s common stock, the Company issued Palladium five-year warrants to purchase up to an aggregate of 22,083 shares of its common stock at an exercise price of $3.00 per share.
	As discussed in Note 11, in July 2014, the Company’s former Chairman exercised and exchanged 216,666 warrants for 108,333 RSUs and 108,333 shares of the Company’s common stock. In addition, a former director of the Company exercised and exchanged 33,333 warrants for 16,666 RSUs and 16,667 shares of the Company’s common stock.
	As discussed in Note 10, in August 2014, in connection with the Company’s public offering of Units, the Company issued five-years warrants to purchase up to an aggregate of 775,000 shares of its commons stock at an exercise price of $3.20 per share.
	As discussed in Note 9, the Company issued 146,667 shares of Series C in exchange for 216,667 warrants, which were cancelled.
	There was no expense pertaining to warrants recorded during the years ended December 31, 2014 and 2013.
	Restricted Stock Awards
	On December 21, 2012, the Company granted 400,000 shares of restricted common shares to its former Chief Executive Officer. Of these shares, 33,333 were fully vested on the date of grant and the remaining shares were scheduled to vest in equal increments of 16,666 shares over a 22-month period, with the first vesting date being January 10, 2013, subject to continued employment on each applicable vesting date. The aggregate grant date fair value of the award amounted to $720,000, based upon the closing market price on the date of grant, which was to be recognized as compensation expense over the vesting period. The Company recorded $270,000 of compensation expense during the year ended December 31, 2013 with respect to this award. On October 16, 2013, the Company’s former Chief Executive Officer resigned from his position and 216,667 unvested shares were forfeited upon his resignation.
	In June 2013, the Company entered into a one year investor relations agreement with a third party consultant. Pursuant to the terms of the agreement, the Company was required to pay a monthly cash fee of $3,000 and issued 18,000 shares of its common stock, with 4,500 shares vesting on a quarterly basis, beginning on the effective date of June 10, 2013. During the years ended December 31, 2014 and 2013, 4,500 shares and 13,500 shares, having a fair value of $21,195 and $35,100, based on the quoted closing trading price of the Company’s common stock as of the grant date, respectively, vested. These amounts were recorded as a prepaid expense and were amortized over the remaining service term. We recorded $30,757 and $25,538 as professional fees expense pertaining to this grant during the years ended December 31, 2014 and 2013, respectively.
On August 15, 2014, the Company renewed the above investor relations agreement with the third party consultant for an additional one-year term, commencing August 15, 2014. Pursuant to the terms of the agreement, the Company is required to pay a monthly cash fee of $3,000 and issued 20,000 shares of its common stock, with 10,000 shares vesting on August 15, 2014 and 10,000 shares vesting on May 15, 2015. The Company recorded $30,500 as a prepaid expense relating to the 10,000 shares of vested common stock, based on the quoted closing trading price of its common stock as of the grant date. This amount is being amortized over the remaining service term. The Company recorded $15,250 as professional fees expense pertaining to this grant during the year ended December 31, 2014.
On October 18, 2013 the Company granted an aggregate of 66,666 shares of restricted common stock to two of its advisors for future services to be provided. The restricted stock vests quarterly over a three year period with the first vesting date being December 31, 2013, subject to continued service on each applicable vesting date. Additionally, the restricted stock will automatically vest under certain circumstances including in the event of a change of control of the Company. During the years ended December 31, 2014 and 2013, 22,224 shares and 5,556 shares, having a fair value of $72,506 and $16,668, based on the quoted closing trading price of the Company’s common stock as of the grant date, respectively, vested. Accordingly, the Company recorded $72,506 and $16,668 as compensation expense pertaining to the vested portion of this grant during the years ended December 31, 2014 and 2013, respectively.
On October 31, 2013, the Company granted 183,331 RSUs to its directors. The RSUs vest annually over a five year period with the first vesting date being October 31, 2014, subject to continued service on each applicable vesting date. Additionally, the RSUs will automatically vest under certain circumstances including in the event of a change of control of the Company. The RSUs will have no voting rights or dividend rights. The fair value of the common stock at the date of grant is $3.45 per share, based upon the closing market price on the date of grant. The aggregate grant date fair value of the award amounts to $632,500, which will be recognized as compensation expense over the vesting period. During the year ended December 31, 2014, 99,999 RSUs were fully vested upon the resignation of three of the Company’s directors. The Company recorded $390,996 and $21,083 of compensation expense during the years ended December 31, 2014 and 2013, respectively, with respect to this award.
On April 11, 2014, the Company granted 150,000 RSUs each to its Chief Executive Officer and Chief Operating Officer. The RSUs vest annually over a five year period with the first vesting date being April 10, 2015, subject to continued service on each applicable vesting date. Additionally, the RSUs will automatically vest under certain circumstances including in the event of a change of control of the Company. The RSUs will have no voting rights or dividend rights. The fair value of the common stock on the date of grant is $4.80 per share, based upon the closing market price on the date of grant. The aggregate grant date fair value of the award amounts to $1,440,000, which is being recognized as compensation expense over the vesting period. The Company recorded $204,000 of compensation expense during the year ended December 31, 2014 with respect to this award.
On May 15, 2014, the Company granted 5,000 shares of fully vested restricted common stock to its Interim Chief Financial Officer for services previously provided. The fair value of the common stock on the date of grant was $4.55 per share, based upon the quoted closing trading price of the Company’s common stock on the grant date. The aggregate grant date fair value of the award amounted to $22,750, which was recorded as compensation expense during the year ended December 31, 2014.
Effective May 19, 2014, the Company granted an aggregate of 146,000 RSUs to its independent directors. The RSUs vest annually over a three year period with the first vesting date being May 19, 2015, subject to continued service on each applicable vesting date. Additionally, the RSUs will automatically vest under certain circumstances including in the event of a change of control of the Company. The RSUs will have no voting rights or dividend rights. The fair value of the common stock on the date of grant is $4.55 per share, based upon the closing market price of the Company’s common stock on the date of grant. The aggregate grant date fair value of the award amounts to $664,300, which is being recognized as compensation expense over the vesting period. During the year ended December 31, 2014, 38,000 unvested RSUs were forfeited upon the resignation of one of the Company’s directors. The Company recorded $102,375 of compensation expense during the year ended December 31, 2014 with respect to this award.
As discussed in Note 11, in July 2014, the Company’s former Chairman exercised and exchanged 216,666 warrants for 108,333 RSUs and 108,333 shares of the Company’s common stock. In addition, a former director of the Company exercised and exchanged 33,333 warrants for 16,666 RSUs and 16,667 shares of the Company’s common stock.
On December 2, 2014, the Company granted an aggregate of 35,000 RSUs to Sunder Raman, the father of our Chief Executive Officer, for future services to be provided as an advisor to the Company. The RSUs vest quarterly over a three year period with the first vesting date being March 2, 2015, subject to continued service on each applicable vesting date. Additionally, the RSUs will automatically vest under certain circumstances including in the event of a change of control of the Company. The RSUs will have no voting rights or dividend rights. The fair value of the common stock on the date of grant is $2.01 per share, based upon the closing market price of the Company’s common stock on the date of grant. The aggregate grant date fair value of the award amounts to $70,350, which is being recognized as compensation expense over the vesting period. The Company recorded $1,954 of compensation expense during the year ended December 31, 2014 with respect to this award.
Including prior period grants and the above grants, the Company recorded non-cash compensation expense of $970,388 and $805,239 during the years ended December 31, 2014 and 2013, respectively.
Total unrecognized compensation expense related to unvested stock awards and unvested restricted stock units at December 31, 2014 amounts to $1,929,084 and is expected to be recognized over a weighted average period of 3.5 years.
A summary of the restricted stock award activity for the year ended December 31, 2014 is as follows:
	Number of
	Shares
Unvested Outstanding at December 31, 2013			248,941
Granted			662,999
Cancelled			-38,000
Vested			-315,388
Unvested Outstanding at December 31, 2014			558,552

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 13 – Income Taxes
	The Company recognizes deferred tax assets and liabilities for both the expected impact of differences between the financial statements and the tax basis of assets and liabilities, and for the expected future tax benefit to be derived from tax losses and tax credit carryforwards. The Company established a valuation allowance to reflect the likelihood of realization of deferred tax assets.
	The domestic and foreign components of the Company’s consolidated net pre-tax loss from operations for the respective periods are as follows:
		Year ended December 31,
			2014	2013
	Domestic loss	$	-7,354,000	$	-4,442,000
	Foreign income (loss)		65,000		179,000
	Consolidated net loss before income tax expense	$	-7,289,000	$	-4,263,000
	The valuation allowance at December 31, 2014 was approximately $13,229,000. The net change in the valuation allowance during the year ended December 31, 2014 was an increase of approximately $2,117,000. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred income tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based on consideration of these items, management has determined that enough uncertainty exists relative to the realization of the deferred income tax asset balances to warrant the application of a full valuation allowance as of December 31, 2014.
	The Company has a net operating loss carryforward totaling approximately $26,700,000 at December 31, 2014, expiring through 2034. Pursuant to Code Sec. 382 of the Internal Revenue Code, the utilization of net operating loss carryforwards may be limited as a result of a cumulative change in stock ownership of more than %50% over a three year period. The Company is subject to examination by federal and state taxing authorities for the 2011 and subsequent tax years. Temporary differences, which give rise to a net deferred tax asset, are approximately as follows:
	Significant deferred tax assets are as follows:
		December 31,
		2014		2013
	Current deferred tax assets:
	Accrued Expenses	$	30,000	$	30,000
	Allowance for Doubtful Accounts		4,000		1,000
	Subtotal current deferred tax asset		34,000		31,000
	Non-current deferred tax assets and liabilities:
	Intangible Assets	$	65,000	$	27,000
	Fixed Assets		-147,000		-123,000
	Discount on Convertible Notes		-		-329,000
	Derivative Liability		-		377,000
	Stock Options		2,673,000		2,477,000
	Net operating loss carryover		10,604,000		8,652,000
	Subtotal non-current deferred tax asset		13,195,000		11,081,000
	Total deferred tax asset	$	13,229,000	$	11,112,000
	Less: valuation allowance		-13,229,000		-11,112,000
	Net deferred tax assets	$	-	$	—
	The actual tax expense (benefit) differs from the expected tax expense (benefit) for the years ended December 31, 2014 and 2013 (computed by applying the U.S. Federal Corporate income tax rate of 34% to income before taxes and 5.5% for State income taxes, a blended rate of 37.63%) as follows:
		December 31,
		2014		2013
	Expected tax expense (benefit) - federal	$	-2,478,000	$	-1,449,000
	Expected tax expense (benefit) - state		-242,000		-159,000
	Foreign rate differential		-2,000		-23,000
	Change in fair value of derivative liability - embedded conversion feature		232,000		—
	Permanent items		2,000		22,000
	True-up		-5,000		-135,000
	Change in valuation allowance		2,493,000		1,744,000
	Actual tax expense	$	-	$	—

Significant_Accounting_Policie1

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation and Principals of Consolidation
	The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
	Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from these estimates.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents
	All highly liquid investments with an original maturity of 90 days or less when purchased are considered to be cash equivalents. Cash equivalents are stated at cost, which approximates market value. Cash equivalents generally consist of money market accounts.
	The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institutions. At times, the Company’s cash may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limit.
Trade and Other Accounts Receivable, Policy [Policy Text Block]	Accounts Receivable and Other Receivables
	Accounts receivable and other receivables represent obligations from the Company’s customers. The Company periodically evaluates the collectability of its accounts receivable and other receivables and considers the need to record an allowance for doubtful accounts based upon historical collection experience and specific information. Actual amounts could vary from the recorded estimates. The allowance for doubtful accounts was $9,642 and $3,500 at December 31, 2014 and 2013, respectively.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment
	Property and equipment represent costs associated with leasehold improvements, software, and computer and office equipment. Property and equipment is stated at cost. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets.
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Intangible Assets
	The Company’s intangible assets pertain to capitalized software costs and its website domain address. The Company capitalizes costs related to software developed or obtained for internal use when management commits to funding the project, the project completes the preliminary project stage and the software will be used to perform the function intended. Capitalization of such costs ceases when the project is substantially complete and ready for its intended use.
	The Company periodically reviews the carrying values of its long-lived assets when events or changes in circumstances indicate that it is more likely than not that their carrying values may exceed their fair values, and records an impairment charge when considered necessary. When circumstances indicate that an impairment of value may have occurred, the Company tests such assets for recoverability by comparing the estimated undiscounted future cash flows expected to result from the use of such assets and their eventual disposition to their carrying amounts. If the undiscounted future cash flows are less that the carrying amount of the asset, an impairment loss, measured as the excess of the carrying amount of the asset over its estimated fair value, is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.
Debt, Policy [Policy Text Block]	Convertible Instruments
	The Company reviews all of its convertible instruments for the existence of an embedded conversion feature which may require bifurcation, if certain criteria are met. These criteria include circumstances in which:
		a)	The economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract,
		b)	The hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable GAAP with changes in fair value reported in earnings as they occur, and
		c)	A separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to certain requirements (except for when the host instrument is deemed to be conventional).
	A bifurcated derivative financial instrument may be required to be recorded at fair value and adjusted to market at each reporting period end date. In addition, the Company may be required to classify certain stock equivalents issued in connection with the underlying debt instrument as derivative liabilities.
	For convertible instruments that the Company has determined should not be bifurcated from their host instruments, the Company records discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. Also when necessary, the Company records deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the financing transaction and the effective conversion price embedded in the preferred shares.
	Finally, if necessary, the Company will determine the existence of liquidated damage provisions. Liquidated damage provisions are not marked to market, but evaluated based upon the probability that a related liability should be recorded.
Common Stock Purchase Warrants And Derivative Financial Instruments [Policy Text Block]	Common Stock Purchase Warrants and Derivative Financial Instruments
	The Company reviews any common stock purchase warrants and other freestanding derivative financial instruments at each balance sheet date and classifies them on the consolidated balance sheet as:
		a)	Equity if they (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement), or
		b)	Assets or liabilities if they (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).
	The Company assesses classification of its common stock purchase warrants and other freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition
	Revenue is recognized when all of the following conditions exist: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred, (3) the sales price is fixed or determinable, and (4) collectability is reasonably assured.
	Seller Electronics Referrals
	Sellers responding to the Company’s advertising campaigns go to uSell’s website where they can search for the items they wish to sell using a streamlined point and click interface. Once they have identified their device, they are asked a single question to describe the condition of the device. At this point, they are presented with the “best match,” or uSell’s recommended offer from one of its buyers. The Company offers this recommendation based on both the price offered by the buyer relative to other buyers and the quality of ratings of the buyer relative to other buyers. The seller may choose to view a larger list of offers from all buyers interested in purchasing their device. During 2013, and into 2014, the Company earned up front “lead fees” from buyers when sellers accepted offers on its website and filled out a form to request a free shipping kit. This fee was received regardless of whether the sellers ultimately sent in their devices to the buyers. The Company recognized revenue upon online acceptance of the buyer’s offer by the seller. The Company records payments received from buyers in advance of offer acceptance as deferred revenue at the time payment is received.
	During 2013, the Company’s buyers paid fees based on the demand for the individual item which the seller was seeking to sell. Fees were not based on the value of the item sold. For instance, an iPhone might have had a higher fee than an Android, even if that particular Android had a higher offer price to the seller.
	Beginning in February 2014, the Company started a transition of its business model, which was phased in over the subsequent six weeks. Under the new model, buyers pay uSell a commission only when they pay the seller for a received device and the Company recognizes revenue upon payment to the seller.
	As a further development to the Company’s business model, in October 2014, the Company launched its “Managed by uSell” service, whereby the Company partnered with a third party logistics company to inspect, wipe and process devices before passing them along to buyers. Under this new model, title to a device passes to uSell upon issuance of payment to the seller, which is generally within one to two days from the receipt of the device at the third party warehouse. Title to a device is then transferred to the buyer upon shipment to the buyer. As a result, starting in October 2014, the Company began recognizing the full value of the processed devices in both revenues and cost of revenues.
	Fulfillment Revenue
	The Company offers fulfillment services on behalf of its buyers for the items sold by sellers. The Company acts as the agent in these transactions, passing orders booked by its buyers to its vendors, who then assemble the kits and mail them directly to the sellers. The Company earns a standard fee from its buyers and recognizes revenue upon shipment of the kits to the sellers. The Company evaluated the presentation of revenue on a gross versus net basis and determined that since the Company performs as an agent without assuming the risks and rewards of ownership of the goods, revenue should be reported on a net basis.
	Advertising Revenue
	Advertising revenues primarily come from payments for text-based sponsored links and display advertisements. Generally, the Company’s advertisers pay the Company on a cost per click, or CPC basis, which means advertisers pay only when someone clicks on one of their advertisements, or on a cost per thousand impression basis, or CPM. Paying on a CPM basis means that advertisers pay the Company based on the number of times their advertisements appear on the Company’s websites or mobile applications. Advertising revenue is recognized as income when the advertising services are rendered.
Cost of Sales, Policy [Policy Text Block]	Cost of Revenue
	Cost of revenue consists primarily of costs to maintain its website, including amortization expense on its technology platform software. Beginning in October 2014, cost of revenue pertaining to the sale of devices to buyers includes the cost of acquiring the device, as well as any other direct costs and expenses required to inspect and process the devices internally before shipping them to the buyers.
Advertising Costs, Policy [Policy Text Block]	Advertising
	Advertising costs are expensed as they are incurred and are included in sales and marketing expenses. Advertising expense amounted to approximately $5,498,000 and $4,461,000 for the years ended December 31, 2014 and 2013, respectively.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Share-Based Payment Arrangements
	The Company accounts for stock options in accordance with Accounting Standards Codification (“ASC”) 718, “Compensation - Stock Compensation.” ASC 718 requires generally that all equity awards be accounted for at their “fair value.” This fair value is measured on the grant date for stock-settled awards, and at subsequent exercise or settlement for cash-settled awards. Fair value is equal to the underlying value of the stock for “full-value” awards such as restricted stock and performance shares, and is estimated using an option-pricing model with traditional inputs for “appreciation” awards such as stock options and stock appreciation rights.
	Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from the Company’s initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense in the accompanying consolidated statements of operations.
	Subsequent modifications to outstanding awards result in incremental cost if the fair value is increased as a result of the modification. Thus, a value-for-value stock option repricing or exchange of awards in conjunction with an equity restructuring does not result in additional compensation cost.
Income Tax, Policy [Policy Text Block]	Income Taxes
	The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
	ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2014. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
	The Company may be subject to potential income tax examinations by federal or state authorities. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. Management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
	The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest as of December 31, 2014.
Earnings Per Share, Policy [Policy Text Block]	Net Loss per Share
	Basic loss per share (“EPS”) is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method, and convertible debt or convertible preferred stock, using the if-converted method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive.
	The computation of basic and diluted loss per share for the years ended December 31, 2014 and 2013 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:
			Years Ended December 31,
			2014		2013
	Convertible Notes Payable				373,333
	Convertible Series A Preferred Stock		100,000		-
	Convertible Series B Preferred Stock		60,415		62,002
	Convertible Series C Preferred Stock		146,667		-
	Convertible Series E Preferred Stock		103,232		-
	Unvested Restricted Stock		48,886		65,610
	Unvested Restricted Stock Units		509,666		183,331
	Stock Warrants		802,520		476,270
	Stock Options		604,625		557,413
			2,376,011		1,717,959
Commitments and Contingencies, Policy [Policy Text Block]	Legal Proceedings
	From time to time, The Company is a party to or otherwise involved in legal proceedings arising in the normal and ordinary course of business. As of the date of this report, the Company is not aware of any proceeding, threatened or pending, against the Company which, if determined adversely, would have a material effect on its business, results of operations, cash flows or financial position.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Customer Concentrations
	The following table shows significant concentrations in the Company’s revenues and accounts receivable for the periods indicated.
			Percentage of
			Revenue During the
			Year Ended
			December 31,
			2014			2013
	Buyer A			15	%		8	%
	Buyer B			7	%		18	%
	Buyer C			6	%		25	%
			Percentage of Accounts
			Receivable at
			December 31,
			2014			2013
	Buyer AA			24	%		35	%
	Buyer BB			3	%		14	%
	Buyer CC			-	%		17	%
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements
	In July 2013, the Financial Accounting Standards Board (“FASB”) issued ASU, No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” (“ASU 2013-11”). ASU 2013-11 provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The guidance is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013, with an option for early adoption. The adoption of this standard did not have a material impact on the Company’s consolidated financial statements.
	In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers” (ASU 201-09). ASU 201-09 provides guidance for revenue recognition and affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets and supersedes the revenue recognition requirements in Topic 605, “Revenue Recognition,” and most industry-specific guidance. The core principle of ASU 2014-09 is the recognition of revenue when a company transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, companies will need to use more judgment and make more estimates than under the current guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective for fiscal years beginning after December 15, 2016 and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). Early adoption is not permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-09 will have on the Company’s consolidated financial statements and disclosures.
	In June 2014, the FASB issued ASU No. 2014-12, “Compensation - Stock Compensation” (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could be Achieved after the Requisite Service Period (“ASU 2014-12”). ASU 2014-12 affects entities that grant their employees share-based payments in which terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments in ASU 2014-12 require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. ASU 2014-12 is effective for fiscal years beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the method and impact the adoption of ASU 2014-12 will have on the Company’s consolidated financial statements and disclosures.
	In August 2014, the FASB issued ASU 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15 provides guidance on management’s responsibility in evaluating whether there is substantial doubt about a company’s ability to continue as a going concern and about related footnote disclosures. For each reporting period, management will be required to evaluate whether there are conditions or events that raise substantial doubt about a company’s ability to continue as a going concern within one year from the date the financial statements are issued. The amendments in ASU 2014-15 are effective for annual reporting periods ending after December 15, 2016, and for annual and interim periods thereafter. Early adoption is permitted. The Company will adopt the methodologies prescribed by ASU 2014-15 by the date required, and does not anticipate that the adoption of ASU 2014-15 will have a material effect on its financial position or results of operations.
Subsequent Events, Policy [Policy Text Block]	Subsequent events
	The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements were issued for potential recognition or disclosure. Any material events that occur between the balance sheet date and the date that the consolidated financial statements were issued are disclosed as subsequent events, while the consolidated financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements.

Significant_Accounting_Policie2

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	The computation of basic and diluted loss per share for the years ended December 31, 2014 and 2013 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:
		Years Ended December 31,
		2014		2013
	Convertible Notes Payable			373,333
	Convertible Series A Preferred Stock	100,000		-
	Convertible Series B Preferred Stock	60,415		62,002
	Convertible Series C Preferred Stock	146,667		-
	Convertible Series E Preferred Stock	103,232		-
	Unvested Restricted Stock	48,886		65,610
	Unvested Restricted Stock Units	509,666		183,331
	Stock Warrants	802,520		476,270
	Stock Options	604,625		557,413
		2,376,011		1,717,959
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]	The following table shows significant concentrations in the Company’s revenues and accounts receivable for the periods indicated.
		Percentage of
		Revenue During the
		Year Ended
		December 31,
		2014			2013
	Buyer A		15	%		8	%
	Buyer B		7	%		18	%
	Buyer C		6	%		25	%
		Percentage of Accounts
		Receivable at
		December 31,
		2014			2013
	Buyer AA		24	%		35	%
	Buyer BB		3	%		14	%
	Buyer CC		-	%		17	%

Fair_Value_Tables

Fair Value (Tables)	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Table Text Block]	The following are the major categories of liabilities measured at fair value on a recurring basis at December 31, 2014 and 2013, using quoted prices in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3):
		At December 31,
		2014				2013
		Assets		Liabilities		Assets		Liabilities
	Level 1
	None	$	-	$	-	$	-	$	-
	Level 2
	None		-		-		-		-
	Level 3
	Derivative liability		-		-		-		1,001,385
		$	-	$	-	$	-	$	1,001,385
Fair Value, by Balance Sheet Grouping [Table Text Block]	The following table reflects the change in fair value of the Company’s derivative liabilities for the years ended December 31, 2014 and 2013:
		Year Ended December 31,
		2014				2013
		Assets		Liabilities		Assets		Liabilities
	Balance at beginning of period	$	-	$	1,001,385	$	-	$	153,776
	Change in value of derivative liability - Series A preferred stock		-		-		-		-47,876
	Reclassification of price protection feature to additional paid in capital - Series A preferred stock		-		-		-		-105,900
	Derivative liability arising from issuance of convertible notes payable		-		-		-		1,244,351
	Change in value of derivative liability - convertible notes		-		681,122		-		-149,398
	Reclassification of price protection feature to additional paid in capital - converted notes		-		-1,682,507		-		-93,568
	Balance at end of period	$	-	$	-	$	-	$	1,001,385

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Property and equipment consists of the following at December 31, 2014 and 2013:
						Estimated
		2014		2013		Useful Life
	Hardware and Software	$	14,216	$	14,721	3 years
	Furniture and Fixtures		5,645		5,645	3 years
			19,861		20,366
	Less: Accumulated Depreciation		-12,933		-13,077
	Property and Equipment, Net	$	6,928	$	7,289

Intangible_Assets_Tables

Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	Intangible assets consist of the following:
		Capitalized		Website
		Software		Domain		Total
	Gross value at December 31, 2014	$	1,974,482	$	67,752	$	2,042,234
	Accumulated amortization at December 31, 2014		-1,122,389		-67,752		-1,190,141
	Net value at December 31, 2014	$	852,093	$	-	$	852,093
	Gross value at December 31, 2013	$	1,317,976	$	67,752	$	1,385,728
	Accumulated amortization at December 31, 2013		-511,012		-67,752		-578,764
	Net value at December 31, 2013	$	806,964	$	-	$	806,964
Finite-lived Intangible Assets Amortization Expense [Table Text Block]	Future annual estimated amortization expense is summarized as follows:
	Years ending December 31,
	2015	$	470,110
	2016		261,281
	2017		120,702
		$	852,093

Convertible_Notes_Tables

Convertible Notes (Tables)	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	On the date of conversion, the Company determined the fair value of the derivative liability to be $1,682,507 using the Black-Scholes option pricing model with the following assumptions:
	Risk-free interest rate	0.22	%
	Expected dividend yield	0	%
	Expected volatility	239.41	%
	%Expected term	1.35 - 1.77 years

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	These options had a fair value of $384,387 using the Black-Scholes option-pricing model with the following assumptions:
	Risk free interest rate		0.54% - 1.37	%
	Expected dividends		0	%
	Expected volatility		204.36% - 219.25	%
	Expected term		5 years
	These options had a fair value of $184,423, using the Black-Scholes option pricing model with the following assumptions:
	Risk free interest rate		1.19% - 1.43	%
	Expected dividends		0	%
	Expected volatility		56.89% - 60.87	%
	Expected term		3.75 – 4.00 years
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	The following table summarizes the Company’s stock option activity for the year ended December 31, 2014:
							Weighted
							Average
					Weighted		Remaining
					Average		Contractual
			Number of		Exercise		Life		Aggregate
			Options		Price		(in Years)		Intrinsic Value
	Outstanding - December 31, 2013			557,413	$	4.98		4	$	5,250
	Granted			128,332		3.41
	Exercised			-		-
	Forfeited or Canceled			-81,120		4.36
	Outstanding - December 31, 2014			604,625	$	4.73		3.3	$	-
	Exercisable - December 31, 2014			348,770	$	5.9		3.2	$	-
Schedule of Nonvested Share Activity [Table Text Block]	The following table summarizes the Company’s stock option activity for non-vested options for the year ended December 31, 2014:
					Weighted
					Average
			Number of		Grant Date
			Options		Fair Value
	Balance at December 31, 2013			237,040	$	4.45
	Granted			128,332		1.44
	Vested			-98,558		-5.45
	Forfeited or Canceled			-10,959		-4.36
	Balance at December 31, 2014			255,855	$	2.65
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	The following summarizes the Company’s warrant activity for the year ended December 31, 2014:
							Weighted
					Weighted		Average
					Average		Remaining		Aggregate
			Number of		Exercise		Contractual Life		Intrinsic
			Warrants		Price		(in Years)		Value
	Outstanding - December 31, 2013			476,269		3.02		3.1	$	-
	Granted			797,083		3.19
	Exercised			-254,165		-3
	Forfeited or Canceled			-216,667		-3
	Outstanding – December 31, 2014			802,520	$	3.21		4.6	$	-
	Exercisable – December 31 2014			802,520	$	3.21		4.6	$	-
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	A summary of the restricted stock award activity for the year ended December 31, 2014 is as follows:
		Number of
		Shares
	Unvested Outstanding at December 31, 2013			248,941
	Granted			662,999
	Cancelled			-38,000
	Vested			-315,388
	Unvested Outstanding at December 31, 2014			558,552

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]	The domestic and foreign components of the Company’s consolidated net pre-tax loss from operations for the respective periods are as follows:
		Year ended December 31,
			2014	2013
	Domestic loss	$	-7,354,000	$	-4,442,000
	Foreign income (loss)		65,000		179,000
	Consolidated net loss before income tax expense	$	-7,289,000	$	-4,263,000
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	Significant deferred tax assets are as follows:
		December 31,
		2014		2013
	Current deferred tax assets:
	Accrued Expenses	$	30,000	$	30,000
	Allowance for Doubtful Accounts		4,000		1,000
	Subtotal current deferred tax asset		34,000		31,000
	Non-current deferred tax assets and liabilities:
	Intangible Assets	$	65,000	$	27,000
	Fixed Assets		-147,000		-123,000
	Discount on Convertible Notes		-		-329,000
	Derivative Liability		-		377,000
	Stock Options		2,673,000		2,477,000
	Net operating loss carryover		10,604,000		8,652,000
	Subtotal non-current deferred tax asset		13,195,000		11,081,000
	Total deferred tax asset	$	13,229,000	$	11,112,000
	Less: valuation allowance		-13,229,000		-11,112,000
	Net deferred tax assets	$	-	$	—
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	The actual tax expense (benefit) differs from the expected tax expense (benefit) for the years ended December 31, 2014 and 2013 (computed by applying the U.S. Federal Corporate income tax rate of 34% to income before taxes and 5.5% for State income taxes, a blended rate of 37.63%) as follows:
		December 31,
		2014		2013
	Expected tax expense (benefit) - federal	$	-2,478,000	$	-1,449,000
	Expected tax expense (benefit) - state		-242,000		-159,000
	Foreign rate differential		-2,000		-23,000
	Change in fair value of derivative liability - embedded conversion feature		232,000		—
	Permanent items		2,000		22,000
	True-up		-5,000		-135,000
	Change in valuation allowance		2,493,000		1,744,000
	Actual tax expense	$	-	$	—

Organization_and_Business_Deta

Organization and Business (Details Textual)	12 Months Ended
	Dec. 31, 2014
Organization and Business [Line Items]
Stockholders Equity, Reverse Stock Split	On January 21, 2014, the Company effected a 1-for-15 reverse stock split of its common stock (Reverse Split). As a result of the Reverse Split, every fifteen shares of common stock was combined into one share of common stock. Immediately after the January 21, 2014 effective date, the Company had 4,907,462 shares of common stock outstanding.

Going_Concern_Details_Textual

Going Concern (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Going Concern [Line Items]
Net Loss	($7,288,482)	($4,262,856)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	-3,484,547	-1,777,864
Accumulated deficit	($52,042,615)	($44,754,133)

Significant_Accounting_Policie3

Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,376,011	1,717,959
Convertible Notes Payable [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		373,333
Convertible Series A Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	100,000	0
Convertible Series B Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	60,415	62,002
Convertible Series C Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	146,667	0
Convertible Series E Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	103,232	0
Unvested Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	48,886	65,610
Unvested Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	509,666	183,331
Stock Warrants [member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	802,520	476,270
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	604,625	557,413

Significant_Accounting_Policie4

Significant Accounting Policies (Details 1)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Buyer A [Member] | Sales Revenue, Net [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	15.00%	8.00%
Buyer B [Member] | Sales Revenue, Net [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	7.00%	18.00%
Buyer C [Member] | Sales Revenue, Net [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	6.00%	25.00%
Buyer AA [Member] | Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	24.00%	35.00%
Buyer BB [Member] | Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	3.00%	14.00%
Buyer CC [Member] | Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	0.00%	17.00%

Significant_Accounting_Policie5

Significant Accounting Policies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Significant Accounting Policies [Line Items]
Allowance for Doubtful Accounts Receivable	$9,642	$3,500
Advertising Expense	$5,498,000	$4,461,000

Fair_Value_Details

Fair Value (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]
Derivative Asset, Fair Value, Net	$0	$0
Derivative Liability, Fair Value, Net	0	1,001,385
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]
Derivative Asset, Fair Value, Net	0	0
Derivative Liability, Fair Value, Net	0	0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]
Derivative Asset, Fair Value, Net	0	0
Derivative Liability, Fair Value, Net	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Rrecurring Basis [Line Items]
Derivative Asset, Fair Value, Net	0	0
Derivative Liability, Fair Value, Net	$0	$1,001,385

Fair_Value_Details_1

Fair Value (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Balance at end of period	$0	$1,001,385
Derivative Financial Instruments, Liabilities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Balance at beginning of period	1,001,385	153,776
Change in value of derivative liability - Series A preferred stock	0	-47,876
Reclassification of price protection feature to additional paid in capital - Series A preferred stock	0	-105,900
Derivative liability arising from issuance of convertible notes payable	0	1,244,351
Change in value of derivative liability - convertible notes	681,122	-149,398
Reclassification of price protection feature to additional paid in capital - converted notes	-1,682,507	-93,568
Balance at end of period	0	1,001,385
Derivative Financial Instruments, Assets [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Balance at beginning of period	0	0
Change in value of derivative liability - Series A preferred stock	0	0
Reclassification of price protection feature to additional paid in capital - Series A preferred stock	0	0
Derivative liability arising from issuance of convertible notes payable	0	0
Change in value of derivative liability - convertible notes	0	0
Reclassification of price protection feature to additional paid in capital - converted notes	0	0
Balance at end of period	$0	$0

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$19,861	$20,366
Less: Accumulated Depreciation	-12,933	-13,077
Property and Equipment, Net	6,928	7,289
Hardware and Software [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	14,216	14,721
Property, Plant and Equipment, Useful Life	3 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$5,645	$5,645
Property, Plant and Equipment, Useful Life	3 years

Property_and_Equipment_Details1

Property and Equipment (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Depreciation	$4,530	$4,862

Intangible_Assets_Details

Intangible Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Gross value	$2,042,234	$1,385,728
Accumulated amortization	-1,190,141	-578,764
Net value	852,093	806,964
Capitalized Software [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	1,974,482	1,317,976
Accumulated amortization	-1,122,389	-511,012
Net value	852,093	806,964
Website Domain [Member]
Finite-Lived Intangible Assets [Line Items]
Gross value	67,752	67,752
Accumulated amortization	-67,752	-67,752
Net value	$0	$0

Intangible_Assets_Details_1

Intangible Assets (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Years ending December 31,
2015	$470,110
2016	261,281
2017	120,702
Net value	$852,093	$806,964

Intangible_Assets_Details_Text

Intangible Assets (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	straight-line basis
Amortization of Intangible Assets	$611,377	$358,131
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	2 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years

Convertible_Notes_Details

Convertible Notes (Details)	12 Months Ended
	Dec. 31, 2014
Debt Conversion [Line Items]
Risk-free interest rate	0.22%
Expected dividend yield	0.00%
Expected volatility	239.41%
Maximum [Member]
Debt Conversion [Line Items]
Expected term	1 year 9 months 7 days
Minimum [Member]
Debt Conversion [Line Items]
Expected term	1 year 4 months 6 days

Convertible_Notes_Details_Text

Convertible Notes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Debt Conversion [Line Items]
Common Stock, Par or Stated Value Per Share	$0.00	$0.00
Derivative, Gain (Loss) on Derivative, Net, Total	($681,122)	$149,398
Interest Expense, Total	891,596	334,678
Convertible Notes Payable [Member]
Debt Conversion [Line Items]
Proceeds from Notes Payable		1,220,000
Accounts Payable, Interest-bearing, Interest Rate		5.00%
Derivative Liability, Fair Value, Gross Liability	1,682,507	1,244,351
Financial Services Costs, Total		61,495
Derivative, Gain (Loss) on Derivative, Net, Total	681,122
Non Cash Interest Expense	873,872	308,984
Interest Expense, Total	8,745	22,788
Notes Payable Fee	10,970
Accretion Expense	8,645	2,325
Debt Conversion, Converted Instrument, Shares Issued		33,514
Debt Conversion, Original Debt, Amount		100,000
Interest Payable		541
Debt Instrument, Convertible, Conversion Price		$3
Debt Instrument, Unamortized Discount	1,182,856	1,182,856
Debt Instrument, Convertible, Terms of Conversion Feature		The Convertible Notes automatically converted if the Company consummated (i) a financing of at least $1 million in which it issued common stock or common stock equivalents for a price greater than $3.75 per share or (ii) a change of control transaction whereby a majority of the Companys outstanding voting stock was sold or there was a sale of substantially all of the Companys assets, or (iii) the closing price of the Companys common stock was more than $4.50 for 10 consecutive trading days.
Convertible Notes Payable [Member] | Series E Preferred Stock [Member]
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued	103,232
Debt Conversion, Original Debt, Amount	300,000
Interest Payable	9,698
Convertible Notes Payable [Member] | Common Stock [Member]
Debt Conversion [Line Items]
Debt Conversion, Converted Instrument, Shares Issued	280,427
Debt Conversion, Original Debt, Amount	820,000
Interest Payable	$21,294
Convertible Notes Payable [Member] | Minimum [Member]
Debt Conversion [Line Items]
Common Stock, Par or Stated Value Per Share		$3

Commitments_and_Contingencies_

Commitments and Contingencies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Loss Contingencies [Line Items]
Operating Leases, Rent Expense	$81,000	$95,000
Operating Leases, Future Minimum Payments Due, Next Twelve Months	$51,750

Preferred_Stock_Details_Textua

Preferred Stock (Details Textual) (USD $)	12 Months Ended		1 Months Ended
	Dec. 31, 2013	Dec. 31, 2014	Jun. 30, 2013	Feb. 28, 2014	Jan. 27, 2014
Convertible Notes Payable [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Debt Conversion, Converted Instrument, Shares Issued	33,514
Interest Payable	$541
Debt Conversion, Original Debt, Amount	100,000
Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues		2,141,666
Stock Issued During Period, Shares, Conversion of Convertible Securities		0
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities		216,667
Third Party Consultant One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues			18,000
Series B Preferred Stock 2010 [Member] | Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Stock, Shares Issued				1,587
Series A Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues		0
Stock Issued During Period, Shares, Conversion of Convertible Securities		0
Series B Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues		0
Stock Issued During Period, Shares, Conversion of Convertible Securities		0
Series B Preferred Stock [Member] | Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Conversion of Stock, Shares Converted				25,000
Series D Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues		0
Stock Issued During Period, Shares, Conversion of Convertible Securities		0
Series B Convertible Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	4,000,000	4,000,000
Preferred stock, par value (in dollars per share)	$0.00	0.0001
Preferred Stock, Liquidation Preference Per Share		1
Preferred stock, shares outstanding	976,250	951,250
Number Of Shares In Each Share On Conversion		0.0635
Series E Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues		0
Stock Issued During Period, Shares, Conversion of Convertible Securities		103,232
Series E Preferred Stock [Member] | Convertible Notes Payable [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		103,232
Interest Payable		9,698
Debt Conversion, Original Debt, Amount		300,000
Series C Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, New Issues		0
Stock Issued During Period, Shares, Conversion of Convertible Securities		0
Series C Convertible Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	146,667	146,667			146,667
Preferred stock, par value (in dollars per share)	$0.00	0.0001
Preferred stock, shares outstanding	0	146,667
Series C Convertible Preferred Stock [Member] | Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities		216,667
Series A Convertible Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	325,000	325,000
Preferred stock, par value (in dollars per share)	$0.00	0.0001
Preferred Stock, Liquidation Preference Per Share		3
Preferred stock, shares outstanding	0	100,000
Proceeds from Issuance of Preferred Stock and Preference Stock		300,000
Stock Issued During Period, Shares, New Issues		100,000
Series E Convertible Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized	103,232	103,232
Preferred stock, par value (in dollars per share)	$0.00	0.0001
Preferred stock, shares outstanding	0	103,232
Series E Convertible Preferred Stock [Member] | Convertible Notes Payable [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Debt Conversion, Converted Instrument, Shares Issued				103,232
Interest Payable		9,698
Debt Conversion, Original Debt, Amount		300,000

Public_Offering_Details_Textua

Public Offering (Details Textual) (USD $)	0 Months Ended	12 Months Ended
	Aug. 15, 2014	Dec. 31, 2014	Dec. 31, 2013
Proceeds from Issuance or Sale of Equity	$3,703,864
Fair Value Assumptions, Expected Volatility Rate		239.41%
Payments of Stock Issuance Costs	100	1,041,686	0
Legal Fees	946,136
Risk-Free Interest Rate		0.22%
Dawson James Securities, Inc. [Member]
Warrant Fair Value	133,355
Aggregate Exercise Price of Warrant	348,750
Stock Issued During Period, Shares, New Issues	93,000
Shares Issued, Price Per Share	$3.75
Proceeds from Issuance or Sale of Equity	100
Fair Value Assumptions, Expected Volatility Rate	60.70%
Fees and Commissions, Other	559,900
Warrant Exercisable Term	5 years
Risk-Free Interest Rate	1.55%
Unit [Member]
Warrant Fair Value	1,204,759
Stock Issued During Period, Shares, New Issues	1,550,000
Shares Issued, Price Per Share	$3
Proceeds from Issuance or Sale of Equity	$4,650,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$3.20
Fair Value Assumptions, Expected Volatility Rate	60.70%
Warrant Exercisable Term	5 years
Risk-Free Interest Rate	1.55%

Common_Stock_Details_Textual

Common Stock (Details Textual) (USD $)	0 Months Ended	12 Months Ended		0 Months Ended	1 Months Ended		0 Months Ended	3 Months Ended	1 Months Ended
	Aug. 15, 2014	Dec. 31, 2014	Dec. 31, 2013	Apr. 10, 2014	Jul. 31, 2014	Jun. 30, 2013	15-May-14	Mar. 31, 2014	Feb. 28, 2014
Class of Stock [Line Items]
Fair Value Assumptions, Expected Volatility Rate		239.41%
Risk-free interest rate		0.22%
Payments of Stock Issuance Costs	$100	$1,041,686	$0
Stock Issued During Period, Value, New Issues		5,383,313
Proceeds from Warrant Exercises		387,500	0
Board of Directors Chairman [Member]
Class of Stock [Line Items]
Warrants Issued During Period Exercise Price Of Warrants				$3
Proceeds from Warrant Exercises				324,999
Warrant Issued During Period, Number of Warrants				216,666	216,666
Board of Directors Chairman [Member] | Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				108,333	108,333
First Month of Service [Member] | Joint Marketing Agreement [Member]
Class of Stock [Line Items]
Professional Fees		40,000
Second Month of Service [Member] | Joint Marketing Agreement [Member]
Class of Stock [Line Items]
Professional Fees		30,000
Third Month of Service [Member] | Joint Marketing Agreement [Member]
Class of Stock [Line Items]
Professional Fees		10,000
Consultant [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Issued for Services		30,000
Stock Issued During Period, Value, Issued for Services		123,744
Consultant Advisor [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Issued for Services		2,000
Stock Issued During Period, Value, Issued for Services		6,056
Allocated Share-based Compensation Expense		123,744
Professional Fees		6,056
Director [Member]
Class of Stock [Line Items]
Warrants Issued During Period Exercise Price Of Warrants				$3
Proceeds from Warrant Exercises				50,000
Warrant Issued During Period, Number of Warrants				33,333	33,333
Director [Member] | Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues					16,666
Third Party Consultant One [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues						18,000
Professional Fees		30,757	25,538
Fully Vested Common Stock Shares Granted During Period			233,333
Common Stock Granted Fair Value			437,500
Third Party Consultant Two [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Issued for Services							20,000
Professional Fees		15,250
Fully Vested Common Stock Shares Granted During Period			1,333
Common Stock Granted Fair Value			4,000
Common Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues		2,141,666
Stock Issued During Period, Value, New Issues		214
Common Stock [Member] | Board of Directors Chairman [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				108,333	108,333
Common Stock [Member] | Private Placement [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues								591,666
Proceeds from Issuance of Private Placement								1,774,999
Payments of Stock Issuance Costs								75,000
Shares Issued, Price Per Share								$0.00
Common Stock [Member] | Director [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				16,667	16,667
Warrant [Member] | Palladium Capital Advisors, LLC [Member]
Class of Stock [Line Items]
Warrants Exercisable Term								5 years
Stock Issued During Period, Shares, New Issues								22,083	22,083
Fair Value Assumptions, Expected Volatility Rate								58.90%
Risk-free interest rate								1.53%
Proceeds from Issuance of Warrants								1,679,449
Payments of Stock Issuance Costs	95,550
Shares Issued, Price Per Share								$3	$3
Stock Issued During Period, Value, New Issues	$62,241

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (Employee Stock Option [Member])	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividends	0.00%	0.00%
Expected term (in years)		5 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.43%	1.37%
Expected volatility	60.87%	219.25%
Expected term (in years)	4 years
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.19%	0.54%
Expected volatility	56.89%	204.36%
Expected term (in years)	3 years 9 months

StockBased_Compensation_Detail1

Stock-Based Compensation (Details 1) (Employee Stock Option [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options, Outstanding - December 31, 2013	557,413
Number of Options, Granted	128,332
Number of Options, Exercised	0
Number of Options, Forfeited or Canceled	-81,120
Number of Options, Outstanding - December 31, 2014	604,625	557,413
Number of Options, Exercisable - December 31, 2014	348,770
Weighted Average Exercise Price, Outstanding - December 31, 2013 (in dollars per share)	$4.98
Weighted Average Exercise Price, Granted (in dollars per share)	$3.41
Weighted Average Exercise Price, Exercised (in dollars per share)	$0
Weighted Average Exercise Price, Forfeited or Canceled (in dollars per share)	$4.36
Weighted Average Exercise Price, Outstanding - December 31, 2014 (in dollars per share)	$4.73	$4.98
Weighted Average Exercise Price, Exercisable - December 31, 2014 (in dollars per share)	$5.90
Weighted Average Remaining Contractual Life, Outstanding (in years)	3 years 3 months 18 days	4 years
Weighted Average Remaining Contractual Life, Exercisable - December 31, 2014 (in years)	3 years 2 months 12 days
Aggregate Intrinsic Value, Options Outstanding (in dollars)	$0	$5,250
Aggregate Intrinsic Value, Options Exercisable - December 31, 2014 (in dollars)	$0

StockBased_Compensation_Detail2

Stock-Based Compensation (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted Average Grant Date Fair Value, Granted (in dollars per share)	$1.44	$2.66
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning Balance at December 31, 2013	237,040
Number of Options, Granted	128,332
Number of Options, Vested	-98,558
Number of Options, Forfeited or Canceled	-10,959
Ending Balance at December 31, 2014	255,855
Weighted Average Grant Date Fair Value, Balance at December 31, 2013 (in dollars per share)	$4.45
Weighted Average Grant Date Fair Value, Granted (in dollars per share)	$1.44
Weighted Average Grant Date Fair Value, Vested (in dollars per share)	($5.45)
Weighted Average Grant Date Fair Value, Forfeited or Canceled (in dollars per share)	($4.36)
Weighted Average Grant Date Fair Value, Balance at December 31, 2014 (in dollars per share)	$2.65

StockBased_Compensation_Detail3

Stock-Based Compensation (Details 3) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants, Outstanding - December 31, 2013	476,269
Number of Warrants, Granted	797,083
Number of Warrants, Exercised	-254,165
Number of Warrants, Forfeited or Canceled	-216,667
Number of Warrants, Outstanding - December 31, 2014	802,520	476,269
Number of Warrants, Exercisable - December 31, 2014	802,520
Weighted Average Exercise Price, Outstanding - December 31, 2013 (in dollars per share)	$3.02
Weighted Average Exercise Price, Granted (in dollars per share)	$3.19
Weighted Average Exercise Price, Exercised (in dollars per share)	($3)
Weighted Average Exercise Price, Forfeited or Canceled (in dollars per share)	($3)
Weighted Average Exercise Price, Outstanding - December 31, 2014 (in dollars per share)	$3.21	$3.02
Weighted Average Exercise Price, Exercisable - December 31, 2014 (in dollars per share)	$3.21
Weighted Average Remaining Contractual Life, Outstanding (in years)	4 years 7 months 6 days	3 years 1 month 6 days
Weighted Average Remaining Contractual Life, Exercisable - December 31, 2014 (in years)	4 years 7 months 6 days
Aggregate Intrinsic Value, Options Outstanding (in dollars)	$0	$0
Aggregate Intrinsic Value, Exercisable - December 31, 2014 (in dollars)	$0

StockBased_Compensation_Detail4

Stock-Based Compensation (Details 4) (Restricted Stock [Member])	12 Months Ended
	Dec. 31, 2014
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning Balance at December 31, 2013	248,941
Number of Shares, Granted	662,999
Number of Shares, Cancelled	-38,000
Number of Shares, Vested	-315,388
Ending Balance at December 31, 2014	558,552

StockBased_Compensation_Detail5

Stock-Based Compensation (Details Textual) (USD $)

12 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

3 Months Ended

0 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Aug. 31, 2014

Oct. 31, 2014

Apr. 11, 2014

19-May-14

15-May-14

Apr. 10, 2014

Jul. 31, 2014

Dec. 31, 2012

Jun. 30, 2013

Feb. 28, 2014

Mar. 31, 2014

Dec. 02, 2014

Nov. 21, 2014

Oct. 30, 2013

Oct. 18, 2014

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation, Total

$1,492,341

$2,147,763

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

$1.44

$2.66

Proceeds from Warrant Exercises

387,500

0

Common Stock, Capital Shares Reserved for Future Issuance

263,918

IPO [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Warrants Issued During Period Exercise Price Of Warrants

$3.20

Warrant Issued During Period, Number of Warrants

775,000

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of Options, Granted

662,999

Allocated Share-based Compensation Expense

270,000

Share-based Compensation, Total

970,388

805,239

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

16,666

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total

1,929,084

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

3 years 6 months

Restricted Stock or Unit Expense

72,506

16,668

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value

720,000

Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

632,500

2013 Employee Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of Options, Granted

144,333

Allocated Share-based Compensation Expense

80,411

35,490

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value

384,387

2013 Employee Stock Option [Member] | Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

$3

2013 Employee Stock Option [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

$4.50

2014 Employee Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of Options, Granted

128,332

Allocated Share-based Compensation Expense

27,152

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value

184,423

2014 Employee Stock Option [Member] | Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

$2.69

2014 Employee Stock Option [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

$5.15

2008 Equity Incentive Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

584,296

300,000

250,000

Warrant [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock Issued During Period, Shares, Conversion of Convertible Securities

216,667

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

$3.21

Common Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock Issued During Period, Shares, New Issues

2,141,666

Stock Issued During Period, Shares, Conversion of Convertible Securities

0

Series C Convertible Preferred Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period

146,667

Series C Convertible Preferred Stock [Member] | Warrant [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock Issued During Period, Shares, Conversion of Convertible Securities

216,667

Chief Executive and Operating Officer [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

The RSUs vest annually over a five year period with the first vesting date being April 10, 2015, subject to continued service on each applicable vesting date.

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period

216,667

Chief Executive and Operating Officer [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of Options, Granted

150,000

Restricted Stock or Unit Expense

204,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

4.8

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

1,440,000

Independent Director [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

The RSUs vest annually over a five year period with the first vesting date being October 31, 2014, subject to continued service on each applicable vesting date.

Independent Director [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of Options, Granted

146,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

$4.55

Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost

102,375

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

664,300

Chief Financial Officer [Member] | Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of Options, Granted

5,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

$4.55

Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost

22,750

Board of Directors Chairman [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Proceeds from Warrant Exercises

324,999

Warrants Issued During Period Exercise Price Of Warrants

$3

Warrant Issued During Period, Number of Warrants

216,666

216,666

Board of Directors Chairman [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock Issued During Period, Shares, New Issues

108,333

108,333

Board of Directors Chairman [Member] | Common Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock Issued During Period, Shares, New Issues

108,333

108,333

Chief Executive Officer [Member] | Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of Options, Granted

400,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

33,333

Third Party Consultant One [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Payments for Fees

3,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

4,500

13,500

4,500

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

21,195

35,100

Professional Fees

30,757

25,538

Stock Issued During Period, Shares, New Issues

18,000

Palladium Capital Advisors, LLC [Member] | Warrant [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock Issued During Period, Shares, New Issues

22,083

22,083

Shares Issued, Price Per Share

$3

$3

Director [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Proceeds from Warrant Exercises

50,000

Warrants Issued During Period Exercise Price Of Warrants

$3

Warrant Issued During Period, Number of Warrants

33,333

33,333

Director [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of Options, Granted

183,331

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

$3.45

Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost

390,996

21,083

Stock Issued During Period, Shares, New Issues

16,666

Director [Member] | Common Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock Issued During Period, Shares, New Issues

16,667

16,667

Director [Member] | Chief Executive and Operating Officer [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost

38,000

Third Party Consultant Two [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Payments for Fees

3,000

Stock Issued During Period, Shares, Issued for Services

20,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

10,000

10,000

Professional Fees

15,250

Third Party Consultant Two [Member] | Subsequent Event [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

10,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

30,500

Warrant Holder [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Proceeds from Warrant Exercises

12,500

Warrant Issued During Period, Number of Warrants

4,166

Consultant Advisor [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Allocated Share-based Compensation Expense

123,744

Stock Issued During Period, Shares, Issued for Services

2,000

Professional Fees

6,056

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

$70,350

Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost

1,954

Consultant Advisor [Member] | Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of Options, Granted

35,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

$2.01

Employee Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation, Total

521,953

1,342,525

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

2 years 8 months 12 days

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period

81,120

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options

642,062

Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

$5.90

Stock Options Granted To Board Of Directors and Executive Officers For Future Services [Member] | Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

22,224

5,556

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

$72,506

$16,668

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

66,666

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Line Items]
Domestic loss	($7,354,000)	($4,442,000)
Foreign income (loss)	65,000	179,000
Consolidated net loss before income tax expense	($7,289,000)	($4,263,000)

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current deferred tax assets:
Accrued Expenses	$30,000	$30,000
Allowance for Doubtful Accounts	4,000	1,000
Subtotal current deferred tax asset	34,000	31,000
Non-current deferred tax assets and liabilities:
Intangible Assets	65,000	27,000
Fixed Assets	-147,000	-123,000
Discount on Convertible Notes	0	-329,000
Derivative Liability	0	377,000
Stock Options	2,673,000	2,477,000
Net operating loss carryover	10,604,000	8,652,000
Subtotal non-current deferred tax asset	13,195,000	11,081,000
Total deferred tax asset	13,229,000	11,112,000
Less: valuation allowance	-13,229,000	-11,112,000
Net deferred tax assets	$0	$0

Income_Taxes_Details_2

Income Taxes (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Line Items]
Expected tax expense (benefit) - federal	($2,478,000)	($1,449,000)
Expected tax expense (benefit) - state	-242,000	-159,000
Foreign rate differential	-2,000	-23,000
Change in fair value of derivative liability - embedded conversion feature	232,000	0
Permanent items	2,000	22,000
True-up	-5,000	-135,000
Change in valuation allowance	2,493,000	1,744,000
Actual tax expense	$0	$0

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Line Items]
Deferred Tax Assets, Valuation Allowance	$13,229,000	$11,112,000
Operating Loss Carryforwards	$26,700,000
Operating Loss Carryforwards Expiration Period	expiring through 2034
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%	34.00%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent	5.50%	5.50%
Effective Income Tax Rate Reconciliation Blended Tax Rate	37.63%	37.63%